These findings suggest that dysregulated steroidogenesis and hormonal fluctuations may contribute to the altered levels of EPAS-1 and ghrelin observed in our study, potentially influencing cardiac and vascular function in SLE. The gene discussed is GHRL; the disease is systemic lupus erythematosus.